Advertisement
UK markets close in 23 minutes
  • FTSE 100

    8,358.65
    +44.98 (+0.54%)
     
  • FTSE 250

    20,452.95
    +39.87 (+0.20%)
     
  • AIM

    779.56
    +3.14 (+0.40%)
     
  • GBP/EUR

    1.1623
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2494
    -0.0016 (-0.13%)
     
  • Bitcoin GBP

    50,047.38
    -1,366.05 (-2.66%)
     
  • CMC Crypto 200

    1,330.99
    +36.32 (+2.80%)
     
  • S&P 500

    5,187.77
    +0.07 (+0.00%)
     
  • DOW

    38,958.61
    +74.35 (+0.19%)
     
  • CRUDE OIL

    78.55
    +0.17 (+0.22%)
     
  • GOLD FUTURES

    2,324.50
    +0.30 (+0.01%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • DAX

    18,486.66
    +56.61 (+0.31%)
     
  • CAC 40

    8,146.81
    +71.13 (+0.88%)
     

GlaxoSmithKline Stock’s June Performance

GlaxoSmithKline Stock’s June Performance

British multinational pharmaceutical company GlaxoSmithKline (GSK) divides its business into three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. As it is a British company, it reports its revenue in British pounds. The chart below shows GlaxoSmithKline’s revenue and EPS since Q1 2017, and analysts’ estimate for Q2 2018.